Drug class review: pharmacologic treatments for attention deficit hyperactivity disorder: final update 4 report

MS McDonagh, K Peterson, S Thakurta, A Low - 2012 - europepmc.org
Purpose Attention deficit hyperactivity disorder (ADHD) affects children and adults and is
treated with both pharmacologic and nonpharmacologic interventions. Multiple drugs are …

[PDF][PDF] Drug Class Review Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder

MS McDonagh, K Peterson, S Thakurta, A Low - Update, 2009 - ohsu.edu
Purpose Attention deficit hyperactivity disorder (ADHD) affects children and adults and is
treated with both pharmacologic and nonpharmacologic interventions. Multiple drugs are …

Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges

M Mosheva, N Dar, LR Madi, A Weizman… - International Clinical …, 2020 - journals.lww.com
Multiple studies have shown that pharmacologic treatments for attention-deficit hyperactivity
disorder (ADHD), especially stimulants, are generally effective. There is yet a paucity of …

Agents for attention-deficit hyperactivity disorder–an update

HR Howard - Expert Opinion on Therapeutic Patents, 2004 - Taylor & Francis
Attention-deficit hyperactivity disorder (ADHD) is a psychological disorder affecting children
and adolescents, whose symptoms often persist into the adult years, and is often effectively …

Recent advances in pharmacological management of attention-deficit/hyperactivity disorder: moving beyond stimulants

A Childress - Expert Opinion on Pharmacotherapy, 2024 - Taylor & Francis
Introduction Attention-deficit/hyperactivity disorder (ADHD) is a common neurobehavioral
disorder characterized by impairing inattention, and/or hyperactivity and impulsivity in …

Drug treatments for attention-deficit hyperactivity disorder in young people

G Bates - Advances in psychiatric treatment, 2009 - cambridge.org
The central role of medication in the treatment of attention-deficit hyperactivity disorder
(ADHD) in children and adolescents is the focus of controversy once more. Questions about …

Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis

SCOS Padilha, S Virtuoso, FS Tonin… - European child & …, 2018 - Springer
The aim of this study is to gather evidence of head-to-head double-blind randomized-
controlled trials on the efficacy and safety of available treatments for attention deficit …

Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association …

B Bolea-Alamañac, DJ Nutt… - Journal of …, 2014 - journals.sagepub.com
Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal
burden. The present guidelines summarise current literature, generating expert consensus …

Current pharmacological treatments for ADHD

MJ Groom, S Cortese - New Discoveries in the Behavioral Neuroscience of …, 2022 - Springer
Abstract Attention-Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental
condition associated with impaired function and increased risk of poor outcomes in children …

The management of attention-deficit hyperactivity disorder in children: Updated 2019

N Schellack, JC Meyer, AK Chigome - SA Pharmaceutical Journal, 2019 - journals.co.za
Attention-deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder and
involves the academic, social and family functioning of the child. It is the most commonly …